Kelly Wilson

Interim CEO & President at Immune Therapeutics

Kelly Wilson is currently the President at Biostax Corp. and has previously held positions such as Chief Operating Officer at Murphy Advisors and Director of Corporate Program Management at Statera BioPharma, Inc. With a background in instructional design and technology, Kelly has experience working in various companies overseeing Information Technology implementation, project planning, training development, and creating online training programs. Kelly holds a Master's degree in Instructional Systems Design from the University of Central Florida.

Links

Previous companies

Reebok logo
Statera BioPharma logo

Org chart

Sign up to view 5 direct reports

Get started